MDA5 is annotated in GOA with GO:0038187 pattern recognition receptor activity (IDA x2), a term
whose GO definition is "Combining with a pathogen-associated molecular pattern (PAMP), a structure
conserved among microbial species to initiate an innate immune response." A 2026 Nature Immunology
paper reports that during actual virus infection MDA5 is bound not to viral RNA but to host RNA. The
curation question is whether the PAMP-based molecular function term still fits.
Verified on PubMed; DOI 10.1038/s41590-026-02614-3; full text cached.
The authors open by conceding that the ligand has never been pinned down:
PMID:42581186
iCLIP of endogenous MDA5 (new monoclonal antibodies) in THP1 and Calu-3 cells infected with EMCV or
SARS-CoV-2:
PMID:42581186, and more starkly
PMID:42581186 Approximately 10% of input reads in SARS-CoV-2-infected cells mapped to the viral genome, yet
there was no enrichment of viral RNA in the MDA5 IP.
The binding sites were intronic and repeat-proximal, and the trigger was removable by fixing splicing:
PMID:42581186.
Proposed reframing:
PMID:42581186 and, in the discussion,
PMID:42581186.
They describe MDA5's status in the field as unresolved:
PMID:42581186.
Crucially, this is a reframing and not a head-to-head rebuttal. The authors say so themselves:
PMID:42581186. Two cell types, two viruses, one lab.
GO:0038187 IDA #1 = PMID:21217758 (Zuest et al., Nat Immunol 2011, verified). Coronaviruses lackingGO:0038187 IDA #2 = PMID:23273991 (Wu et al., Cell 2013, verified; cached entry is abstract-only).GO:0003725 dsRNA binding: IBA + IDA (PMID:19656871) + TAS. Uncontested.GO:0003725 dsRNA binding -> ACCEPT, core. Not in dispute under either model; the host ligandsGO:0038187 pattern recognition receptor activity -> ACCEPT, core, with the dispute recorded inreason. Not REMOVE (two IDAs whose full text I have not read, and the Wu 2013 duplex resultproposed_new_terms entry ("aberrant cellular RNA sensor activity") and asuggested_questions item rather than being settled by an edit here.GO:0003677 DNA binding (IEA) -> REMOVE. Traced to source: GO_REF:0000002 is InterPro2GO, andGO:0016787 hydrolase activity (same InterPro source) -> MODIFY to GO:0016887.GO:0003724 RNA helicase activity -> MODIFY to GO:0008186 (ATP-dependent activity, acting onGO:0009597 detection of virus -> KEEP_AS_NON_CORE. The BP term most exposed to the iCLIP result.GO:0005634 nucleus (IEA from the UniProt location vocabulary) -> MARK_AS_OVER_ANNOTATED.GO:0016925 protein sumoylation (involved_in) -> MARK_AS_OVER_ANNOTATED; MDA5 is the substrate,GO:0005739 mitochondrion -> KEEP_AS_NON_CORE; conditional, post-activation relocalisation toGO:0005515 protein binding and GO:0019904 protein domain specific binding ->GO:0042802 identical protein binding kept as ACCEPT, becauseWhether the iCLIP result and the in vitro viral-ligand results are in conflict at all. Purified MDA5
demonstrably binds long viral duplexes; iCLIP reports what MDA5 is crosslinked to inside an infected
cell, where viral RNA may be shielded in replication organelles. The authors themselves argue this is
the resolution rather than a contradiction. I did not find a 2025-26 paper that tests the two models
against each other directly.
Rows: GO:0005739 mitochondrion, IDA PMID:33727702 and IEA GO_REF:0000044 (SL-0173). No sub-compartment rows; qualifier located_in.
Checks:
- UniProt "Mitochondrion {ECO:0000269|PubMed:33727702}. Note=Upon viral RNA stimulation and ISGylation, translocates from cytosol to mitochondrion." [file:human/IFIH1/IFIH1-uniprot.txt].
- PMID:33727702 (full text cached): kit-based fractionation, 10,000 g pellet; "Anti-α-tubulin and anti-MAVS immunoblotting served as markers for the cytosolic and mitochondrial fractions, respectively." No ER marker, and MAVS is also on MAM and peroxisomes, so the pellet does not separate mitochondrion from MAM.
Outcome: both rows stay KEEP_AS_NON_CORE; the reason no longer says "outer membrane", which the paper does not show; YAML anchor on supported_by replaced by explicit lists. Stays at root (TRAF3 precedent).